Dr. Martin (San Francisco Bay Area, California, USA) has more than 35 years of multinational Pharma and Biotech R&D experience. Most recently, he was President & CEO of Takeda Ventures Inc., and a board member at 16 of the Takeda Ventures portfolio companies. Prior to this, he held among others senior positions at Telik Inc., a Bay Area oncology publicly listed biotech company, and at Roche Biosciences, where he was VP of CNS Research USA.
Ms. Mårtensson (Stockholm, Sweden) has held positions in marketing and sales of medical technical & analytical instruments in Europe, USA and Asia. Between 1998 and 2014, she was CEO of Cellavision AB [STO: CEVI], which she led from a start-up company till a global listed company. She is Chairman of Elos Medtech AB [STO: ELOS-B] and Director of Synthetic MR AB [SYNT:SS], Biotage AB [BIOT:SS] and SwedenBio.
Dr. Thestrup-Nielsen (Lausanne, Switzerland) is VP and Sr. leadership mentor with the corporate M&A team at Danaher Corporation [SWX: DHR], where he led several acquisitions incl. Beckman Coulter, a $7B diagnostics deal. Simultaneously, he served as Chairman and CEO of Pantheon Group, a portfolio company of Permira Advisers, and served on the board of Oncimmune Ltd [LON: ONC], Dr. Thestrup-Nielsen spent 10 years in the US focusing on venture capital & private equity.
Mr. Odermatt (Lucerne, Switzerland) is founder of and partner at Value Solutions Group. His previous experience includes serving as Head of Center of Competence Valuation and Member of the Managing Team for Corporate Finance/Corporate Recovery at KPMG Switzerland; More than 10 years as CFO at Prionics, a world leader in animal diagnostic acquired by Thermo Fisher in 2014, as well as a number of board and management positions in international companies.
Dr. Reddington (Denver, Colorado, USA) is President and CEO of Morris Animal Foundation, a global leader in funding scientific studies. Dr. Reddington was the COO for Cambridge Biomedical Inc., a laboratory CRO. President and CEO of Sirtex Medical, Inc. US division (ASX: SIR), COO and SVP of R&D for the publicly traded company Valentis Inc. John also founded DiagXotics Inc. and led it to become the world leader in disease diagnosis.
Dr. Thorball (Lucerne, Switzerland) has more than 30 years' experience as a serial entrepreneur & innovator and has an international business track from senior corporate positions at Pharmacia (Pfizer), Rhone-Poulenc-Rorer (Sanofi), and Novozymes [NZYM-B.CO]. He is a former board member of BioGaia AB, inventor of its successful product range and a board member at ViroGates A/S, 1CryoBio GmbH and YourGlobalEye ApS.
3Brain is a passionate and ambitious team working in one of the most promising and future-oriented sectors: neuroscience. In 3Brain we work hard to develop tangible technology that has positive, long-lasting impacts on our society.
Even if no open positions are available, we are always more than willing to consider high-achieving candidates passionate about joining our dynamic company. Please send your resume and a short cover letter to firstname.lastname@example.org.